|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/4174 | (2006.01) |
| A61P 31/16 | (2006.01) |
| (11) | Number of the document | 1802302 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05784163.7 |
| Date of filing the European patent application | 2005-09-16 | |
| (97) | Date of publication of the European application | 2007-07-04 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-26 |
| (46) | Date of publication of the claims translation | 2017-02-10 |
| (86) | Number | PCT/EP2005/010026 |
| Date | 2005-09-16 |
| (87) | Number | WO 2006/037452 |
| Date | 2006-04-13 |
| (30) | Number | Date | Country code |
| 102004049008 | 2004-10-05 | DE |
| (72) |
SACHER, Fritz, DE
TSCHAIKIN, Marion, DE
KOELSCH, Stephan, DE
|
| (73) |
The Procter & Gamble Company,
One Procter & Gamble Plaza, Cincinnati, OH 45202,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | LFA-simpatomimetikų, turinčių 2-imidazolino struktūra, naujas panaudojimas |
| NOVEL USE OF alpha-SYMPATHOMIMETICS HAVING A 2-IMIDAZOLINE STRUCTURE |
| Payment date | Validity (years) | Amount | |
| 2018-08-23 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-09-16 |